Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Tetrabutylammonium is a phase-transfer agent commonly used in PET radiochemistry. Its toxicity makes its quantification mandatory. However, the official HPLC method for tetrabutylammonium analysis reported in the European Pharmacopoeia (Ph. Eur.) apparently fails to achieve the described separation in most new generation reverse-phase columns. The study highlights the differences in separation achievable by varying some of the chromatographic conditions, such as temperature, eluent composition and ion-pairing agent concentration. In the end, variations to the method within the limits allowed by the Ph. Eur. were not sufficient to overcome the problem, thus forcing to a more radical change of the organic component of the mobile phase. © 2019 John Wiley & Sons, Ltd.

Citation

Anna Bogni, Luca Laera, Claudio Cucchi, Ettore Seregni, Claudio Pascali. Tetrabutylammonium HPLC analysis: shortcomings in the Ph. Eur. method. Journal of labelled compounds & radiopharmaceuticals. 2020 Apr;63(4):203-208

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 31887241

View Full Text